Scanner Helps Find Areas Most at Risk to Develop Pressure Ulcers

Bruin Biometrics (BBI) is looking to shake up the way patients are assessed for pressure ulcers with its SEM scanner. FDA granted de novo marketing authorization for the device which can help uncover a patient’s risk for bedsores and gauge whether there is tissue damage. The current standard for assessing pressure ulcers requires clinicians or healthcare givers to visually inspect patients' skin and remember to turn them over in their beds every few hours. The current standard also relies on risk assessment scales that judge which patients are most at risk for developing pressure ulcers and monitor them. “There was a desperate need for an evidence-based methodology to assess risk of the anatomy of developing a pressure ulcer,” Martin Burns, BBI’s CEO, told MD+DI. “So, when you’re posed with that question on whether the patient is at risk for a pressure ulcer and where, the SEM Scanner now says this reads the patient’s left heel at risk for a pressure ulcer. We know that because scanner is showing the value is over and above the threshold which indicates that risk.” The device looks to evaluate subepidermal moisture, which is a physical marker associated with localized edema in the initial inflammatory phase of pressure ulcer formation. Are you ready for MD&M West? Join us from Feb. 5 - Feb. 7 for medtech's premiere eve...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Sterilization Source Type: news